| Catalog No. | Size | Price (USD) |
| 10014-MM11-50 | 50 µL | $147.96 |
| 10014-MM11-100 | 100 µL | $251.64 |
| 10014-MM11-200 | 200 µL | $355.32 |
General Information
| Product name | Anti-basic FGF/FGF2 Antibody, Mouse Monoclonal |
| Validated applications | ELISA (FAQ Protocol) |
| Species reactivity | Reacts with: Human |
| Specificity | Human basic FGF/FGF2 |
| Immunogen | Recombinant Human bFGF/FGF2 Protein (Catalog#10014-HNAE) |
| Preparation | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human bFGF/FGF2 (rh bFGF/FGF2; Catalog#10014-HNAE; NP_001997.5; Pro143-Ser288). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
| Source | Monoclonal Mouse IgG1 Clone #11 |
| Purification | Protein A |
| Formulation | 0.2 μm filtered solution in PBS |
| Conjugate | Unconjugated |
| Form | Liquid |
| Shipping | This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Storage | This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles. |
Synonyms: Anti-BFGF Antibody; Anti-FGF-2 Antibody; Anti-FGFB Antibody; Anti-HBGF-2 Antibody
Background Information
| Full Name | fibroblast growth factor 2 (basic) |
| Description | Basic fibroblast growth factor (bFGF), also known as FGF2, is a member of the fibroblast growth factor (FGF) family. It is a highly specific chemotactic and mitogenic factor for many cell types, appears to be involved in remodeling damaged tissue, such as ulcer healing, vascular repair, traumatic brain injury (TBI). bFGF is a critical component of human embryonic stem cell culture medium. In addition, bFGF protein is a heparin-binding cationic protein involved in a variety of pathological conditions including angiogenesis and solid tumour growth. Thus, bFGF is regarded as a target for cancers chemopreventive and therapeutic strategies. |
| Research Areas |
|
| References |
|
title: Potent retro-inverso D-peptide for simultaneous targeting of angiogenic blood vasculature and tumor cells.
authors: Ying Li; Yang Lei; ...; Min Liu
journal: Bioconjugate Chemistry
date: 2013-06-24
pmid: 23241015
doi: 10.1021/bc300537z
cited_by_count: 13
techniques: Cell Culture; Modification
bioz_score: 90
